iifl-logo

Eiko Lifesciences Ltd Share Price

48.34
(-0.64%)
May 9, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open48.65
  • Day's High48.89
  • 52 Wk High74.88
  • Prev. Close48.65
  • Day's Low47.26
  • 52 Wk Low 42
  • Turnover (lac)0.96
  • P/E57.92
  • Face Value10
  • Book Value37.95
  • EPS0.84
  • Mkt. Cap (Cr.)66.33
  • Div. Yield0
View All Historical Data
No Records Found

Eiko Lifesciences Ltd KEY RATIOS

Sector

Chemicals

Open

48.65

Prev. Close

48.65

Turnover(Lac.)

0.96

Day's High

48.89

Day's Low

47.26

52 Week's High

74.88

52 Week's Low

42

Book Value

37.95

Face Value

10

Mkt Cap (₹ Cr.)

66.33

P/E

57.92

EPS

0.84

Divi. Yield

0

Eiko Lifesciences Ltd Corporate Action

30 Jun 2023

12:00 AM

Rights

arrow

24 Jan 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

16 Sep 2024

12:00 AM

BookCloser

arrow

9 Sep 2024

12:00 AM

AGM

Announcement Date: 09 Sep, 2024

arrow

Eiko Lifesciences Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Eiko Lifesciences Ltd SHAREHOLDING SNAPSHOT

09 May, 2025|05:46 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 36.22%

Foreign: 0.00%

Indian: 36.22%

Non-Promoter- 63.77%

Institutions: 0.00%

Non-Institutions: 63.77%

Custodian: 0.00%

Share Price

Eiko Lifesciences Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

12.87

8.32

8.32

10.16

Preference Capital

0

0

0

0

Reserves

37.81

21.11

20.31

2.37

Net Worth

50.68

29.43

28.63

12.53

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2016Mar-2015

Revenue

25.41

11.99

0

0

yoy growth (%)

111.93

0

0

0

Raw materials

-22.58

-10.61

0

0

As % of sales

88.86

88.5

0

0

Employee costs

-0.27

-0.11

0

0

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2016Mar-2015

Profit before tax

0.94

0.83

0

0

Depreciation

-0.56

-0.06

0

0

Tax paid

-0.23

-0.21

0

0

Working capital

2.57

7.66

0.67

0.07

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2016Mar-2015

Growth matrix (%)

Revenue growth

111.93

0

0

0

Op profit growth

148.21

0

0

0

EBIT growth

52.76

0

0

0

Net profit growth

14.87

0

0

0

View Ratios
Particulars (Rupees in Crores.)Mar-2020Mar-2019Mar-2018

Gross Sales

10.35

4.25

2.34

Excise Duty

0

0

0

Net Sales

10.35

4.25

2.34

Other Operating Income

0

0

0

Other Income

0.06

0.06

0.06

Eiko Lifesciences Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Pidilite Industries Ltd

PIDILITIND

2,955.95

76.051,50,354.03445.760.542,850.86169.79

SRF Ltd

SRF

2,947.35

73.387,366.77279.860.252,681.89367.56

Linde India Ltd

LINDEINDIA

6,051.25

118.8451,605.06113.990.2605.86416.08

Gujarat Fluorochemicals Ltd

FLUOROCHEM

3,932.35

87.4443,196.861530.081,123559.21

Godrej Industries Ltd

GODREJIND

1,110.3

360.4937,389.580.201,022.8952.72

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Eiko Lifesciences Ltd

Management

Register Office

Registrar Office

Chairman (Non-Executive)

Laxmikant Kabra

Non-Exec & Non-Independent Dir

Bhavesh Dhirajlal Tanna

Independent Non Exe. Director

Rajkumar K Baheti

Independent Non Exe. Director

Kajal Dhanpatraj Kothari

Whole-time Director

Umesh Ravindranath More

Company Sec. & Compli. Officer

Chintan Doshi

Independent Non Executive Director / CEO

Hasti Doshi

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Eiko Lifesciences Limited was originally incorporated on January 07, 1977, under the name Narendra Investments (Delhi) Limited. Later, the Company changed its name from Narendra Investments (Delhi) Limited to Eiko LifeSciences Limited effective from June 24, 2021. Earlier, the Company engaged in sale and purchase of shares and securities. At present, the Company is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and globally. The Company commenced new business activity primarily in manufacturing of speciality and fine chemicals in October, 2020 from manufacturing facility located at Badlapur, Maharashtra and has since scaled its operations, grown brand and customer base to become the one of the fastest growing speciality chemicals companies in India. The key products manufactured by Company are used in pharmaceutical and agrochemical industries with various end use application including corrosion control, photographic chemicals, solvents, and corrosion inhibitors amongst others.In 2022, it completed the development of new molecules for Agrochemical Intermediates, Polymer Science and Pharma segment. Eiko developed these molecules and launched the same during the second quarter of FY 2022. The Company has ventured in the business of manufacturing, processing, formulating, producing, buying, selling, and exporting Speciality and Fine Chemicals in year 2023. These products find application in a host of Agrochemical, Personal
Read More

Company FAQs

What is the Eiko Lifesciences Ltd share price today?

The Eiko Lifesciences Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹48.34 today.

What is the Market Cap of Eiko Lifesciences Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Eiko Lifesciences Ltd is ₹66.33 Cr. as of 09 May ‘25

What is the PE and PB ratio of Eiko Lifesciences Ltd?

The PE and PB ratios of Eiko Lifesciences Ltd is 57.92 and 1.28 as of 09 May ‘25

What is the 52 Week High and Low of Eiko Lifesciences Ltd?

The 52-week high/low is the highest and lowest price at which a Eiko Lifesciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Eiko Lifesciences Ltd is ₹42 and ₹74.88 as of 09 May ‘25

What is the CAGR of Eiko Lifesciences Ltd?

Eiko Lifesciences Ltd's CAGR for 5 Years at 44.28%, 3 Years at 8.05%, 1 Year at -7.77%, 6 Month at -27.38%, 3 Month at -10.44% and 1 Month at -3.51%.

What is the shareholding pattern of Eiko Lifesciences Ltd?

The shareholding pattern of Eiko Lifesciences Ltd is as follows:
Promoters - 36.23 %
Institutions - 0.00 %
Public - 63.77 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.